| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Norgestrel | FAERS: 6 | US FAERS | |
| 2 | niraparib | FAERS: 4 | US FAERS | |
| 3 | Fingolimod Hydrochloride | FAERS: 2 | US FAERS | |
| 4 | NuvaRing | FAERS: 2 | US FAERS | |
| 5 | Tacrolimus | FAERS: 2 | US FAERS | |
| 6 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 7 | Bosentan | FAERS: 1 | US FAERS | |
| 8 | Paroxetine | FAERS: 1 | US FAERS | |
| 9 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 10 | paricalcitol | FAERS: 1 | US FAERS | |
| 11 | pazopanib | FAERS: 1 | US FAERS | |
| 12 | Paroxetine | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.